AnaptysBio Inc buy JPMorgan Chase & Co.
Start price
19.12.24
/
50%
€14.50
Target price
19.12.25
€34.70
Performance (%)
182.76%
End price
20.12.25
€41.00
Summary
This prediction ended on 20.12.25 with a price of €41.00. With a performance of 182.76% the BUY prediction by JPMorgan_Chase___Co_ was a big success. JPMorgan_Chase___Co_ has a follow-up prediction for AnaptysBio Inc where he still thinks AnaptysBio Inc is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| AnaptysBio Inc | -20.319% | -20.319% | 149.667% |
| iShares Core DAX® | -0,20 % | 5,47 % | 9,19 % |
| iShares Nasdaq 100 | 2,57 % | 10,09 % | 39,29 % |
| iShares Nikkei 225® | 0,60 % | 9,87 % | 46,20 % |
| iShares S&P 500 | 1,80 % | 7,40 % | 29,62 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target lowered by analysts at JPMorgan Chase & Co. from $66.00 to $36.00. They now have an "overweight" rating on the stock.
Ratings data for ANAB provided by MarketBeat
In the thread Trading AnaptysBio Inc
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten